Celebrating an Achievement – and Advancing Cancer Research with CRISPR

Please join us in congratulating Kelly Banas on the successful defense of her PhD research thesis. Upon graduation from the University of Delaware this May, the soon-to-be-conferred Doctor Banas is eager to continue her unique contributions to the field of cancer research. Earlier this year, she was the lead author on a scholarly research paper entitled, “Kinetics of Nuclear Uptake and Site-Specific DNA Cleavage during CRISPR-Directed Gene Editing in Solid Tumor Cells,” published in Molecular Cancer Research. An editor for the journal commented on the value of this work by stating, “the high specificity of CRISPR gene editing technology has made it an attractive candidate for use in clinical gene therapy, particularly in cancer… the data provide an empirical basis for the use of CRISPR-directed gene therapy in solid tumor cells and continue to advance the use of this technology closer to clinical implementation.”

Kinetics of Nuclear Uptake and Site-Specific DNA Cleavage during CRISPR-Directed Gene Editing in Solid Tumor Cells | Molecular Cancer Research